Correction to: High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer

doi:10.12998/wjcc.v13.i13.100700

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (89)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=68

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=15

May 6, 2025 (publication date) through Jan 18, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Correction

World J Clin Cases. May 6, 2025; 13(13): 100700
Published online May 6, 2025. doi: 10.12998/wjcc.v13.i13.100700

Correction to: High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer

Shan Yang, Tian-Li Hui, Hao-Qi Wang, Xi Zhang, Yun-Zhe Mi, Meng Cheng, Wei Gao, Cui-Zhi Geng, Sai-Nan Li

Shan Yang, Tian-Li Hui, Hao-Qi Wang, Xi Zhang, Yun-Zhe Mi, Meng Cheng, Wei Gao, Cui-Zhi Geng, Sai-Nan Li, Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China

Author contributions: All authors have written, read, and approved the correction.

Conflict-of-interest statement: All authors declare no relevant conflicts of interest associated with this article.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Sai-Nan Li, MD, Department of Breast Center, The Fourth Hospital of Hebei Medical University, No. 169 Tianshan Street, Shijiazhuang 050011, Hebei Province, China. 48402144@hebmu.edu.cn

Received: August 23, 2024
Revised: October 12, 2024
Accepted: October 22, 2024
Published online: May 6, 2025
Processing time: 141 Days and 1.2 Hours

Abstract

This is an erratum to the published paper titled, “High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer.” We have removed the citations to certain articles in subsequent revisions of the manuscript. However, owing to our oversight, the citation marker in the upper right corner was not removed. We apologize for any confusion this may have caused.

Keywords: World Journal of Clinical Cases; Correction

Core Tip: This manuscript serves to correct the references in the article titled “High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer. World J Clin Cases 2023; 11(20): 4788-4799 PMID: 37583983 DOI: 10.12998/wjcc.v11.i20.4788”.